Brett Sandercock - Apr 11, 2022 Form 4 Insider Report for RESMED INC (RMD)

Role
Chief Financial Officer
Signature
Brett Sandercock, Chief Financial Officer
Stock symbol
RMD
Transactions as of
Apr 11, 2022
Transactions value $
-$473,100
Form type
4
Date filed
4/12/2022, 05:54 PM
Previous filing
Mar 14, 2022
Next filing
Jul 26, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Options Exercise $144K +2.5K +2.35% $57.76 109K Apr 11, 2022 Direct F1
transaction RMD ResMed Common Stock Sale -$618K -2.5K -2.3% $247.00 106K Apr 11, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RMD ResMed Common Stock Options Options Exercise $0 -2.5K -20% $0.00 10K Apr 11, 2022 ResMed Common Stock 2.5K $57.76 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction was conducted under a Rule 10b5-1 plan.
F2 Represents date options first became exercisable. Options vest 1/3 per year.